Shenzhen Salubris Pharmaceuticals Co Ltd, based in China, is a pharmaceutical company.
One of their notable products is BIVALIRUDIN, with a corresponding US DMF Number 30215.
Remarkably, this DMF maintains an Active status since its submission on March 09, 2016, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of June 03, 2016, and payment made on March 08, 2016, indicating their dedication to facilitating drug approvals, Categorized as Type II